Connor, Clark & Lunn Investment Management (CC&L)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.87M | Sell |
46,429
-108,351
| -70% | -$14.3M | 0.01% | 676 |
|
|
2026
Q1 | $21.6M | Buy |
154,780
+152,432
| +6,492% | +$21.3M | 0.05% | 308 |
|
|
2025
Q4 | $288K | Sell |
2,348
-14,234
| -86% | -$1.73M | ﹤0.01% | 1396 |
|
|
2025
Q3 | $1.84M | Buy |
16,582
+10,513
| +173% | +$1.19M | 0.01% | 878 |
|
|
2025
Q2 | $673K | Sell |
6,069
-205,706
| -97% | -$21.9M | ﹤0.01% | 1168 |
|
|
2025
Q1 | $23.7M | Buy |
211,775
+27,172
| +15% | +$2.8M | 0.1% | 162 |
|
|
2024
Q4 | $17.1M | Buy |
184,603
+142,089
| +334% | +$12.8M | 0.08% | 200 |
|
|
2024
Q3 | $3.56M | Sell |
42,514
-929,649
| -96% | -$70.9M | 0.02% | 524 |
|
|
2024
Q2 | $66.7M | Buy |
972,163
+196,672
| +25% | +$13.1M | 0.28% | 83 |
|
|
2024
Q1 | $56.8M | Buy |
775,491
+689,570
| +803% | +$53M | 0.24% | 89 |
|
|
2023
Q4 | $6.96M | Buy |
85,921
+38,837
| +82% | +$3.02M | 0.03% | 345 |
|
|
2023
Q3 | $3.53M | Buy |
47,084
+19,436
| +70% | +$1.49M | 0.02% | 480 |
|
|
2023
Q2 | $2.13M | Sell |
27,648
-153,844
| -85% | -$12.3M | 0.01% | 598 |
|
|
2023
Q1 | $15.1M | Buy |
181,492
+135,982
| +299% | +$11.3M | 0.08% | 188 |
|
|
2022
Q4 | $3.91M | Buy |
45,510
+4,166
| +10% | +$330K | 0.02% | 400 |
|
|
2022
Q3 | $2.55M | Buy |
41,344
+12,849
| +45% | +$810K | 0.02% | 444 |
|
|
2022
Q2 | $1.76M | Sell |
28,495
-335,610
| -92% | -$20.8M | 0.01% | 497 |
|
|
2022
Q1 | $21.6M | Buy |
364,105
+217,083
| +148% | +$13.9M | 0.11% | 148 |
|
|
2021
Q4 | $10.7M | Buy |
147,022
+80,182
| +120% | +$5.52M | 0.05% | 233 |
|
|
2021
Q3 | $4.67M | Sell |
66,840
-6,916
| -9% | -$486K | 0.02% | 352 |
|
|
2021
Q2 | $5.08M | Buy |
73,756
+5,370
| +8% | +$359K | 0.03% | 356 |
|
|
2021
Q1 | $4.42M | Sell |
68,386
-14,813
| -18% | -$955K | 0.02% | 387 |
|
|
2020
Q4 | $4.85M | Buy |
83,199
+35,480
| +74% | +$2.14M | 0.03% | 344 |
|
|
2020
Q3 | $3.02M | Sell |
47,719
-30,553
| -39% | -$2.12M | 0.02% | 401 |
|
|
2020
Q2 | $6.02M | Buy |
78,272
+23,010
| +42% | +$1.76M | 0.04% | 267 |
|
|
2020
Q1 | $4.13M | Sell |
55,262
-3,495
| -6% | -$241K | 0.04% | 285 |
|
|
2019
Q4 | $3.82M | Buy |
58,757
+1,750
| +3% | +$114K | 0.03% | 315 |
|
|
2019
Q3 | $3.61M | Sell |
57,007
-15,300
| -21% | -$1M | 0.02% | 312 |
|
|
2019
Q2 | $4.88M | Sell |
72,307
-31,950
| -31% | -$2.1M | 0.03% | 290 |
|
|
2019
Q1 | $6.78M | Buy |
104,257
+44,625
| +75% | +$2.97M | 0.04% | 237 |
|
|
2018
Q4 | $3.73M | Sell |
59,632
-44,743
| -43% | -$3.13M | 0.03% | 316 |
|
|
2018
Q3 | $8.06M | Buy |
104,375
+39,075
| +60% | +$2.95M | 0.05% | 243 |
|
|
2018
Q2 | $4.63M | Sell |
65,300
-350
| -0.5% | -$24.7K | 0.03% | 321 |
|
|
2018
Q1 | $4.95M | Sell |
65,650
-100,383
| -60% | -$7.98M | 0.03% | 278 |
|
|
2017
Q4 | $11.9M | Buy |
166,033
+16,258
| +11% | +$1.23M | 0.07% | 186 |
|
|
2017
Q3 | $12.1M | Sell |
149,775
-63,150
| -30% | -$4.83M | 0.07% | 182 |
|
|
2017
Q2 | $15.1M | Buy |
212,925
+149,125
| +234% | +$9.92M | 0.1% | 143 |
|
|
2017
Q1 | $4.33M | Sell |
63,800
-100
| -0.2% | -$7.03K | 0.03% | 270 |
|
|
2016
Q4 | $4.58M | Buy |
63,900
+400
| +0.6% | +$29.7K | 0.03% | 262 |
|
|
2016
Q3 | $5.02M | Sell |
63,500
-198,850
| -76% | -$16.2M | 0.04% | 245 |
|
|
2016
Q2 | $21.9M | Sell |
262,350
-64,725
| -20% | -$5.74M | 0.16% | 110 |
|
|
2016
Q1 | $30M | Sell |
327,075
-127,200
| -28% | -$11.5M | 0.23% | 72 |
|
|
2015
Q4 | $46M | Sell |
454,275
-146,200
| -24% | -$15.2M | 0.38% | 44 |
|
|
2015
Q3 | $59M | Buy |
600,475
+308,325
| +106% | +$34.2M | 0.48% | 43 |
|
|
2015
Q2 | $34.2M | Buy |
+292,150
| New | +$31.9M | 0.31% | 55 |
|
|
2014
Q4 | – | Sell |
-161,700
| Closed | -$17.2M | – | 604 |
|
|
2014
Q3 | $17.2M | Sell |
161,700
-128,600
| -44% | -$12.6M | 0.14% | 76 |
|
|
2014
Q2 | $25.6M | Buy |
+290,300
| New | +$22.6M | 0.18% | 73 |
|
|
2014
Q1 | – | Sell |
-258,173
| Closed | -$20.6M | – | 708 |
|
|
2013
Q4 | $20.6M | Buy |
258,173
+170,743
| +195% | +$11.9M | 0.16% | 69 |
|
|
2013
Q3 | $5.65M | Sell |
87,430
-17,800
| -17% | -$1.06M | 0.05% | 102 |
|
|
2013
Q2 | $5.69M | Buy |
+105,230
| New | +$5.48M | 0.05% | 96 |
|
Other funds holding GILD
Connor, Clark & Lunn Investment Management (CC&L)'s GILD Position: Q2 2026 in Review
Connor, Clark & Lunn Investment Management (CC&L) reduced its Gilead Sciences (GILD) stake by 70% in Q2 2026, selling an estimated $14.3M and leaving 46,429 shares worth $5.87M. The position accounts for 0.01% of the portfolio, ranked #676.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in GILD in Q2 2013 and has held it in 50 quarters since. The position peaked at $66.7M in Q2 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) held 46,429 shares of Gilead Sciences worth $5.87M as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) sold 108,351 Gilead Sciences shares in Q2 2026, an estimated $14.3M.
- Gilead Sciences made up 0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #676 holding.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Gilead Sciences in Q2 2013 and has held it in 50 quarters since.
- Connor, Clark & Lunn Investment Management (CC&L)'s Gilead Sciences position peaked at $66.7M in Q2 2024.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.